These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2757062)

  • 1. Fatal labetalol-induced hepatic injury.
    Douglas DD; Yang RD; Jensen P; Thiele DL
    Am J Med; 1989 Aug; 87(2):235-6. PubMed ID: 2757062
    [No Abstract]   [Full Text] [Related]  

  • 2. Fatal hepatotoxicity induced by hydralazine or labetalol.
    Stumpf JL
    Pharmacotherapy; 1991; 11(5):415-8. PubMed ID: 1745625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Labetalol hepatotoxicity.
    Clark JA; Zimmerman HJ; Tanner LA
    Ann Intern Med; 1990 Aug; 113(3):210-3. PubMed ID: 2375555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Labetalol-induced hepatitis in a patient with chronic hepatitis B infection.
    Marinella MA
    J Clin Hypertens (Greenwich); 2002; 4(2):120-1. PubMed ID: 11927791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of labetalol-induced hepatitis.
    Stronkhorst A; Bosma A; van Leeuwen DJ
    Neth J Med; 1992 Apr; 40(3-4):200-2. PubMed ID: 1603212
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatocellular necrosis associated with labetalol.
    Long RC; Wofford MR; Harkins KG; Minor DS
    J Clin Hypertens (Greenwich); 2007 Apr; 9(4):287-90. PubMed ID: 17396073
    [No Abstract]   [Full Text] [Related]  

  • 7. Labetalol hepatotoxicity.
    Thiele DL
    Am J Med; 1989 Sep; 87(3):361. PubMed ID: 2773977
    [No Abstract]   [Full Text] [Related]  

  • 8. Labetalol hepatotoxicity.
    Ann Intern Med; 1991 Feb; 114(4):341. PubMed ID: 2018583
    [No Abstract]   [Full Text] [Related]  

  • 9. [Toxic hepatocellular hepatitis due to labetalol].
    Castiella A; Iglesias U; Zapata E; Zubiaurre L; Iribarren A
    Gastroenterol Hepatol; 2015 May; 38(5):326-7. PubMed ID: 25073680
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cholestatic síndrome due to labetalol].
    Vicuña-Arregui M; Ruiz-Clavijo-García D; Zozaya-Urmeneta JM; Bolado-Concejo F; Nantes-Castillejo O
    Rev Esp Enferm Dig; 2010 Apr; 102(4):287. PubMed ID: 20486755
    [No Abstract]   [Full Text] [Related]  

  • 11. Results obtained from labetalol therapy in essential hypertension.
    Cagatay G; Soydan I
    Int J Clin Pharmacol Ther Toxicol; 1987 Feb; 25(2):110-2. PubMed ID: 3557731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Labetalol in hypertension.
    Louis WJ; Brignell MJ; McNeil JJ; Christophidis N; Vajda FJ
    Lancet; 1978 Feb; 1(8061):452-3. PubMed ID: 75487
    [No Abstract]   [Full Text] [Related]  

  • 13. Hypersensitivity immune reaction as a mechanism for dilevalol-associated hepatitis.
    Maria VA; Victorino RM
    Ann Pharmacother; 1992; 26(7-8):924-6. PubMed ID: 1504402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term treatment of hypertension with labetalol.
    Erichs M; Rothgardt NP; Andersson E
    Postgrad Med J; 1980; 56 Suppl 2():53-6. PubMed ID: 7433343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative trial of labetalol and acebutolol, alone or associated with dihydralazine, in treatment of essential hypertension.
    Thibonnier M; Lardoux MD; Corvol P
    Br J Clin Pharmacol; 1980 Jun; 9(6):561-7. PubMed ID: 6992823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of labetalol and propranolol in hypertension.
    Nicholls DP; Husaini MH; Bulpitt CJ; Stephens MD; Butler AG
    Br J Clin Pharmacol; 1980 Mar; 9(3):233-7. PubMed ID: 6988003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Open evaluation of labetalol in the treatment of angina pectoris occurring in hypertensive patients.
    Besterman EM; Spencer M
    Br J Clin Pharmacol; 1979; 8(Suppl 2):205S-209S. PubMed ID: 526402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible revelation of latent myasthenia gravis by labetalol chlorhydrate.
    Leys D; Pasquier F; Vermersch P; Gosset D; Michiels H; Kassiotis P; Petit H
    Acta Clin Belg; 1987; 42(6):475-6. PubMed ID: 3434123
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical trial of labetalol (Tranedate) in general practice].
    Mathisen R; Sveen K
    Tidsskr Nor Laegeforen; 1983 Feb; 103(5):541-3. PubMed ID: 6223408
    [No Abstract]   [Full Text] [Related]  

  • 20. [Acute hemodynamic effect of labetalol in severe hypertension].
    Omvik P; Lund-Johansen P
    Tidsskr Nor Laegeforen; 1980 Nov; 100(33):1971-4. PubMed ID: 7456057
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.